Human health effects of traffic-related air pollution (TRAP): a scoping review protocol.


Journal

Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575

Informations de publication

Date de publication:
29 08 2019
Historique:
received: 30 01 2019
accepted: 16 07 2019
entrez: 30 8 2019
pubmed: 30 8 2019
medline: 15 9 2020
Statut: epublish

Résumé

Traffic-related air pollution (TRAP) is one of the major sources of exposure in urban areas and has been associated with a wide range of adverse human health effects. Much of the Canadian population is regularly exposed to TRAP as a result of daily activities (e.g., commuting) and a significant portion of the population resides in close proximity to major roadways. The objective of this scoping review is to develop an evidence map of the epidemiological literature of the human health effects of exposure to TRAP, to support future reviews and assessments by Health Canada. Literature searches will be conducted in Ovid EMBASE and Ovid MEDLINE database. DistillerSR will be used to manage the review process. Two reviewers will independently screen the studies in a two-part process (title and abstract; full text) for eligibility. Epidemiological studies and reviews will be included if they report on the human health effects of exposure to TRAP. Data collection will include study design parameters and human health outcomes evaluated in the study. A descriptive analysis will be used to provide a high-level summary of the number of studies evaluating the different types of health effects and cross-tabulations by study design parameters. The scoping review will be used to identify subject areas for more detailed review and evaluation of the human health effects of TRAP by the Air Health Effects Assessment Division of Health Canada.

Sections du résumé

BACKGROUND
Traffic-related air pollution (TRAP) is one of the major sources of exposure in urban areas and has been associated with a wide range of adverse human health effects. Much of the Canadian population is regularly exposed to TRAP as a result of daily activities (e.g., commuting) and a significant portion of the population resides in close proximity to major roadways. The objective of this scoping review is to develop an evidence map of the epidemiological literature of the human health effects of exposure to TRAP, to support future reviews and assessments by Health Canada.
METHODS
Literature searches will be conducted in Ovid EMBASE and Ovid MEDLINE database. DistillerSR will be used to manage the review process. Two reviewers will independently screen the studies in a two-part process (title and abstract; full text) for eligibility. Epidemiological studies and reviews will be included if they report on the human health effects of exposure to TRAP. Data collection will include study design parameters and human health outcomes evaluated in the study. A descriptive analysis will be used to provide a high-level summary of the number of studies evaluating the different types of health effects and cross-tabulations by study design parameters.
DISCUSSION
The scoping review will be used to identify subject areas for more detailed review and evaluation of the human health effects of TRAP by the Air Health Effects Assessment Division of Health Canada.

Identifiants

pubmed: 31464631
doi: 10.1186/s13643-019-1106-5
pii: 10.1186/s13643-019-1106-5
pmc: PMC6714303
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

223

Références

Environ Res. 2016 Jul;148:513-526
pubmed: 27155984
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
Lancet. 2017 Feb 18;389(10070):718-726
pubmed: 28063597
Air Qual Atmos Health. 2018;11(2):209-220
pubmed: 29568337
CMAJ. 2013 Dec 10;185(18):1557-8
pubmed: 24144607

Auteurs

Carlyn J Matz (CJ)

Air Health Effects Assessment Division, Health Canada, 269 Laurier Ave W, Ottawa, ON, K1A 0K9, Canada. carlyn.matz@canada.ca.

Marika Egyed (M)

Air Health Effects Assessment Division, Health Canada, 269 Laurier Ave W, Ottawa, ON, K1A 0K9, Canada.

Robyn Hocking (R)

Information/Knowledge Management Division, Health Canada, 200 Eglantine Driveway, Ottawa, ON, K1A 0K9, Canada.

Shayesta Seenundun (S)

Air Health Effects Assessment Division, Health Canada, 269 Laurier Ave W, Ottawa, ON, K1A 0K9, Canada.

Nick Charman (N)

Air Health Effects Assessment Division, Health Canada, 269 Laurier Ave W, Ottawa, ON, K1A 0K9, Canada.

Nigel Edmonds (N)

Air Health Effects Assessment Division, Health Canada, 269 Laurier Ave W, Ottawa, ON, K1A 0K9, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH